Skip to main content
Live · TradingView
Back to the NewsWire

Kalkine

Published September 15, 2026 · Updated September 16, 2026

Entropy Neurodynamics (ASX: ENP) in Focus: Could This ASX Biotech Stock Be One to ...

Read the full story at Kalkine

Formerly known as Tryp Therapeutics, the company is developing psilocin-based therapies combined with structured psychedelic -assisted psychotherapy.

Surfaced by this Google Alert

  • Psychedelic biotech